Genetic analysis of the individual contribution to virulence of the type III effector inventory of Pseudomonas syringae pv. phaseolicola.

PloS One
Alberto P MachoCarmen R Beuzón

Abstract

Several reports have recently contributed to determine the effector inventory of the sequenced strain Pseudomonas syringae pv. phaseolicola (Pph) 1448a. However, the contribution to virulence of most of these effectors remains to be established. Genetic analysis of the contribution to virulence of individual P. syringae effectors has been traditionally hindered by the lack of phenotypes of the corresponding knockout mutants, largely attributed to a high degree of functional redundancy within their effector inventories. In support of this notion, effectors from Pseudomonas syringae pv. tomato (Pto) DC3000 have been classified into redundant effector groups (REGs), analysing virulence of polymutants in the model plant Nicotiana benthamiana. However, using competitive index (CI) as a virulence assay, we were able to establish the individual contribution of AvrPto1(Pto) (DC3000) to Pto DC3000 virulence in tomato, its natural host, even though typically, contribution to virulence of AvrPto1 is only shown in strains also lacking AvrPtoB (also called HopAB2), a member of its REG. This report raised the possibility that even effectors targeting the same defence signalling pathway may have an individual contribution to virulence, and po...Continue Reading

References

May 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·R K TaylorJ J Mekalanos
May 1, 1995·Molecular Plant-microbe Interactions : MPMI·C Ritter, J L Dangl
Apr 1, 1997·Molecular Plant-microbe Interactions : MPMI·L W KeithJ E Partridge
Mar 14, 1998·Proceedings of the National Academy of Sciences of the United States of America·A J BogdanoveS V Beer
Feb 21, 2002·Proceedings of the National Academy of Sciences of the United States of America·Derrick E FoutsAlan Collmer
Jun 24, 2004·Proceedings of the National Academy of Sciences of the United States of America·Sruti DebRoySheng Yang He
Jul 31, 2004·Annual Review of Phytopathology·James R Alfano, Alan Collmer
Sep 28, 2004·TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik·W MarczewskiC Gebhardt
Feb 11, 2005·Proceedings of the National Academy of Sciences of the United States of America·Jeff H ChangJeffery L Dangl
Jul 27, 2005·Molecular Plant-microbe Interactions : MPMI·Melisa T S Lim, Barbara N Kunkel
Mar 15, 2006·Molecular Plant-microbe Interactions : MPMI·Jorge L BadelAlan Collmer
Jun 24, 2006·The Plant Journal : for Cell and Molecular Biology·Marta de TorresJens Boch
Dec 7, 2006·Proceedings of the National Academy of Sciences of the United States of America·Yulei ShangJian-Min Zhou
Dec 26, 2007·Current Biology : CB·Tingting XiangJian-Min Zhou
Apr 22, 2008·Annual Review of Phytopathology·Maeli MelottoSheng Yang He
Apr 22, 2008·Annual Review of Phytopathology·Vera Göhre, Silke Robatzek
Apr 22, 2008·Proceedings of the National Academy of Sciences of the United States of America·Timothy K EitasJeffery L Dangl
Jan 24, 2009·Molecular Plant Pathology·Alberto P MachoCarmen R Beuzón

❮ Previous
Next ❯

Citations

Jan 1, 2015·Nature Plants·Marta de Torres ZabalaMurray Grant
Feb 2, 2018·FEMS Microbiology Letters·Juan José González Plaza
May 31, 2019·The Plant Journal : for Cell and Molecular Biology·Feng Y CaoDarrell Desveaux
Jul 12, 2019·Frontiers in Microbiology·Alessandro PasseraBirgit Mitter
Aug 10, 2021·Frontiers in Plant Science·Jeffrey K Schachterle, Qi Huang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Bacterial Protein Structures

Bacterial protein structures can expedite the development of novel antibiotics. Here is the latest research on bacterial proteins and the resolution of their structures.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.